Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine augmentation of exposure therapy for PTSD
NL-OMON25674Not yet recruiting
- Sponsor
- Pro Persona
- Start
- Jan 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing D-cycloserine + exposure therapy with Placebo + exposure therapy (2 arms). Primary endpoint: PTSD symptom severity. Planned start Jan 2008; status: not yet recruiting.
02
Drugs
d-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON25674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25674.